what is glp 1 agonist glp-1_analogs [TUSOM Evolution of GLP‐1 Receptor Agonists

doi: 10.3390/pharmaceutics16060693

For patients already meeting indications for use of a GLP-1 drug based on metabolic factors, its potential role in lowering uveitis risk could be an added consideration when selecting antihyperglycemic therapy. 1 While these possibilities are positive advancements, a commentary on the study, also published yesterday in JAMA Ophthalmology , provides some potential limitations to keep in mind when interpreting conclusions

In this case, it seems to be the 65/20 rule for processed food and drink

You just need to know where to look

doi: 10.2337/dc13-1283

Some reports expect the weight-loss market alone to reach US$ 100 billion by the end of the decade, while NASH has been estimated to be a US$ 35 billion opportunity